SAMHSA Report on Digital Therapeutics in Behavioral Health highlights our work.
Our collaborative work with Dartmouth’s Center for Technology and Behavioral Health (CTBH), Kaiser Permanente, and IBM Research, on using smartphones and wearables to detect relapse in Opioid Use Disorder treatment was highlighted in the Substance Abuse and Mental Health Services Administration’s (SAMHSA) July 2023 Advisory, Digital Therapeutics for Management and Treatment in Behavioral Health.
The report notes:
the first group to launch a line of digital phenotyping research with individuals in medication treatment for opioid use disorder to evaluate how data captured in everyday life from smartphones/smartwatches can increase our understanding of drug lapse events, medication non-adherence, and treatment dropout. Results indicate that passively collected data from smartphones and wearable sensors can be used to predict future non-prescribed opioid use and other clinically important events with high precision and precise timing. These data may inform just-in-time delivery of DTx.